DENTSPLY SIRONA (NASDAQ:XRAY) Cut to “Hold” at Jefferies Financial Group

Jefferies Financial Group cut shares of DENTSPLY SIRONA (NASDAQ:XRAYFree Report) from a buy rating to a hold rating in a research note released on Thursday morning, Marketbeat reports. The brokerage currently has $20.00 price objective on the medical instruments supplier’s stock, down from their prior price objective of $30.00.

XRAY has been the topic of several other research reports. Evercore ISI reiterated an “in-line” rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Mizuho began coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price on the stock. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Ten equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $26.67.

Get Our Latest Analysis on XRAY

DENTSPLY SIRONA Stock Up 0.5 %

DENTSPLY SIRONA stock opened at $19.53 on Thursday. The business has a fifty day moving average price of $19.03 and a 200-day moving average price of $22.67. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $35.68. The stock has a market capitalization of $3.88 billion, a price-to-earnings ratio of -9.43, a PEG ratio of 1.80 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.49 earnings per share. Equities research analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.28%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Large investors have recently bought and sold shares of the business. UMB Bank n.a. increased its position in shares of DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after buying an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in DENTSPLY SIRONA in the 3rd quarter worth $27,000. Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA during the third quarter worth $35,000. MassMutual Private Wealth & Trust FSB lifted its holdings in DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,232 shares in the last quarter. Finally, Van ECK Associates Corp purchased a new position in DENTSPLY SIRONA during the third quarter valued at $42,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.